SCHEMBL16628980

SCHEMBL16628980

Nc1ncc(-c2cccc(S(=O)(=O)N3CCCC3)c2)nc1I

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.53
GAA P10253 4/20 0.52
ALDH1A1 P00352 8/20 0.52
HSD17B10 Q99714 4/20 0.52
USP2 O75604 3/20 0.52
HPGD P15428 3/20 0.52
KDM4E B2RXH2 2/20 0.52
ESR1 P03372 1/20 0.52
GLA P06280 1/20 0.52
TSHR P16473 3/20 0.50
MAPT P10636 3/20 0.50
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
MAPK1 P28482 2/20 0.50
CCNE2 O96020 3/20 0.49
CCNE1 P24864 3/20 0.49
CDK2 P24941 3/20 0.49
GSK3B P49841 3/20 0.49
SMN1; SMN2 Q16637 2/20 0.47
CYP1A2 P05177 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15308588 0.86 NPSR1 (0.58) NPSR1GAAALDH1A1HSD17B10USP2
SCHEMBL19309166 0.83 NPSR1 (0.53) NPSR1GAAALDH1A1HSD17B10USP2
SCHEMBL17718287 0.83 NPSR1 (0.53) NPSR1GAAALDH1A1HSD17B10USP2
SCHEMBL16628998 0.81 ATR (0.49)
SCHEMBL17657921 0.78 ALDH1A1 (0.50) GAAALDH1A1HSD17B10HPGDKDM4E
SCHEMBL17657856 0.77 PIK3CD (0.53)
SCHEMBL3409495 0.77 GSK3B (0.63) ALDH1A1USP2HPGDTSHRMAPT
SCHEMBL4008289 0.77 ATR (0.73) ALDH1A1HSD17B10KDM4ETSHRMAPT
SCHEMBL17657923 0.77 BRD4 (0.49) NPSR1ALDH1A1HPGDKDM4ETSHR
SCHEMBL17657874 0.77 PIK3CD (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4066834-A1 HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF PI3K-GAMMA MEDIATED DISORDERS Infinity Pharmaceuticals, Inc. (US) 2022-10-05 EP disclosed
WO-2015051241-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF INFINITY PHARMACEUTICALS, INC. (US) 2015-04-09 WO disclosed